Of note, the TAP studies which did (i.e., SDD regimens) versus did not (i.e., SOD regimens) include PPAP within the intervention demonstrated greater protection against both overall bacteremia and overall VAP (Table 1). This evidence concerns the gene SOD1 and ventilator-associated pneumonia.